Completed PHASE1 INTERVENTIONAL 2-arm NCT00576394

Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients

Sponsor: American Heart Association

Conditions Glycemic Control

Interventions IV Insulin drip Insulin

Updated 5 times since 2017 Last updated: Jun 22, 2015 Started: Oct 31, 2006 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Glycemic Control, this trial is completed. The trial is conducted by American Heart Association and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Heart Association
Eli Lilly and Company

Data source: American Heart Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States